These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 32266164)
1. Combined Effects of HLA-B*57/5801 Elite Suppressor CD8+ T Cells and NK Cells on HIV-1 Replication. May ME; Pohlmeyer CW; Kwaa AK; Mankowski MC; Bailey JR; Blankson JN Front Cell Infect Microbiol; 2020; 10():113. PubMed ID: 32266164 [TBL] [Abstract][Full Text] [Related]
2. Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro. O'Connell KA; Han Y; Williams TM; Siliciano RF; Blankson JN J Virol; 2009 May; 83(10):5028-34. PubMed ID: 19211742 [TBL] [Abstract][Full Text] [Related]
3. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice. Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323 [TBL] [Abstract][Full Text] [Related]
4. Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers. Tomescu C; Duh FM; Hoh R; Viviani A; Harvill K; Martin MP; Carrington M; Deeks SG; Montaner LJ AIDS; 2012 Sep; 26(15):1869-78. PubMed ID: 22874514 [TBL] [Abstract][Full Text] [Related]
5. KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in Zhang X; Lu X; Moog C; Yuan L; Liu Z; Li Z; Xia W; Zhou Y; Wu H; Zhang T; Su B Front Immunol; 2018; 9():1855. PubMed ID: 30147699 [No Abstract] [Full Text] [Related]
6. Case report: mechanisms of HIV elite control in two African women. Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775 [TBL] [Abstract][Full Text] [Related]
7. Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8 Kwaa AKR; Talana CAG; Blankson JN J Virol; 2019 Feb; 93(3):. PubMed ID: 30404799 [TBL] [Abstract][Full Text] [Related]
8. Suppression of HIV Replication by CD8(+) Regulatory T-Cells in Elite Controllers. Lu W; Chen S; Lai C; Lai M; Fang H; Dao H; Kang J; Fan J; Guo W; Fu L; Andrieu JM Front Immunol; 2016; 7():134. PubMed ID: 27148256 [TBL] [Abstract][Full Text] [Related]
9. Both HLA-B*57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllers. Lécuroux C; Sáez-Cirión A; Girault I; Versmisse P; Boufassa F; Avettand-Fenoël V; Rouzioux C; Meyer L; Pancino G; Lambotte O; Sinet M; Venet A J Virol; 2014 Jan; 88(1):176-87. PubMed ID: 24131719 [TBL] [Abstract][Full Text] [Related]
10. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. Alter G; Martin MP; Teigen N; Carr WH; Suscovich TJ; Schneidewind A; Streeck H; Waring M; Meier A; Brander C; Lifson JD; Allen TM; Carrington M; Altfeld M J Exp Med; 2007 Nov; 204(12):3027-36. PubMed ID: 18025129 [TBL] [Abstract][Full Text] [Related]
11. Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller. Walker-Sperling VE; Pohlmeyer CW; Veenhuis RT; May M; Luna KA; Kirkpatrick AR; Laeyendecker O; Cox AL; Carrington M; Bailey JR; Arduino RC; Blankson JN EBioMedicine; 2017 Feb; 16():141-149. PubMed ID: 28159573 [TBL] [Abstract][Full Text] [Related]
12. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles. Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762 [TBL] [Abstract][Full Text] [Related]
13. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. Bailey JR; O'Connell K; Yang HC; Han Y; Xu J; Jilek B; Williams TM; Ray SC; Siliciano RF; Blankson JN J Virol; 2008 Aug; 82(15):7395-410. PubMed ID: 18495769 [TBL] [Abstract][Full Text] [Related]
14. Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors. Bailey JR; Brennan TP; O'Connell KA; Siliciano RF; Blankson JN J Virol; 2009 Jan; 83(1):88-97. PubMed ID: 18945771 [TBL] [Abstract][Full Text] [Related]
15. An HIV elite controller patient carrying the homozygous H63D variant in the homeostatic iron regulator gene: A case report. Zanella I; Focà E; Degli-Antoni M; Castelli F; Quiros-Roldan E Medicine (Baltimore); 2021 Nov; 100(45):e27732. PubMed ID: 34766580 [TBL] [Abstract][Full Text] [Related]
16. Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers. French MA; Center RJ; Wilson KM; Fleyfel I; Fernandez S; Schorcht A; Stratov I; Kramski M; Kent SJ; Kelleher AD AIDS; 2013 Feb; 27(4):519-28. PubMed ID: 23364441 [TBL] [Abstract][Full Text] [Related]
17. Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes. Costa P; Rusconi S; Mavilio D; Fogli M; Murdaca G; Pende D; Mingari MC; Galli M; Moretta L; De Maria A AIDS; 2001 May; 15(8):965-74. PubMed ID: 11399978 [TBL] [Abstract][Full Text] [Related]
18. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells. Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383 [TBL] [Abstract][Full Text] [Related]
19. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576 [TBL] [Abstract][Full Text] [Related]
20. An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults. Vieira VA; Adland E; Malone DFG; Martin MP; Groll A; Ansari MA; Garcia-Guerrero MC; Puertas MC; Muenchhoff M; Guash CF; Brander C; Martinez-Picado J; Bamford A; Tudor-Williams G; Ndung'u T; Walker BD; Ramsuran V; Frater J; Jooste P; Peppa D; Carrington M; Goulder PJR PLoS Pathog; 2021 Nov; 17(11):e1010090. PubMed ID: 34793581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]